298 related articles for article (PubMed ID: 17625444)
1. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
[TBL] [Abstract][Full Text] [Related]
4. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
[No Abstract] [Full Text] [Related]
5. Hypercalcaemia caused by a carcinoid tumour.
Brzozowska MM; Wolmarans L; Conaglen JV
Intern Med J; 2009 Jun; 39(6):415-8. PubMed ID: 19580622
[TBL] [Abstract][Full Text] [Related]
6. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Milanesi A; Yu R; Wolin EM
Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
[TBL] [Abstract][Full Text] [Related]
7. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
Mantzoros CS; Suva LJ; Moses AC; Spark R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.
Links M; Ho H; Clingan P; Diamond T
Med J Aust; 1994 Mar; 160(5):286-7. PubMed ID: 8107631
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)--associated hypercalcemia of malignancy.
Clemens P; Gregor M; Lamberts R
Exp Clin Endocrinol Diabetes; 2001; 109(7):378-85. PubMed ID: 11573150
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.
Kamp K; Feelders RA; van Adrichem RC; de Rijke YB; van Nederveen FH; Kwekkeboom DJ; de Herder WW
J Clin Endocrinol Metab; 2014 Sep; 99(9):3060-9. PubMed ID: 24905065
[TBL] [Abstract][Full Text] [Related]
11. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
12. Malignant hypercalcemia in vulvar cancer.
Bilenchi R; Poggiali S; Pisani C; Santopietro R; Miracco C; Vatti R; Lucani B; Andreassi A; Gonnelli S
Minerva Ginecol; 2005 Oct; 57(5):569-74. PubMed ID: 16205603
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
Bundred NJ; Walls J; Ratcliffe WA
Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
[TBL] [Abstract][Full Text] [Related]
14. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
[TBL] [Abstract][Full Text] [Related]
15. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
[TBL] [Abstract][Full Text] [Related]
16. Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.
Abraham P; Ralston SH; Hewison M; Fraser WD; Bevan JS
Postgrad Med J; 2002 Dec; 78(926):752-3. PubMed ID: 12509695
[TBL] [Abstract][Full Text] [Related]
17. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma.
Kinugasa Y; Morishige K; Kamiura S; Tsukamoto Y; Saji F
Jpn J Clin Oncol; 2006 Feb; 36(2):113-5. PubMed ID: 16418186
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid-hormone-related-protein-associated hypercalcemia in a patient with CLL-type low-grade leukemic B-cell lymphoma.
Schöttker B; Heinz W; Weissinger F; Sözener K; Eck M; Seufert J
Haematologica; 2006 Dec; 91(12 Suppl):ECR45. PubMed ID: 17194651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]